摘要
轻度认知障碍(MCI)的基础,随着年龄的增加而改变。我们推测,MRI信号轻度认知障碍(MCI)在一个较高的年龄较年轻人会不同。从Sydney记忆和老龄化问题研究以及Sydney百岁老人的选出的研究方法–244参与者(71-103年)被归类为遗忘型MCI、非遗忘型MCI(naMCI)或认知正常(CN)。脑萎缩和白质高信号(WMH)与MCI亚型和年龄相关被广义线性模型研究,并控制混杂因素。减少逻辑回归分析进行确定结构其可最好的区分 aMCI 从CN< 85个人和那些≥85的人体。结果–aMCI与整体皮质体积有关,颞叶内侧结构,与CN相比选择出胼胝体前部的额叶和顶叶区域;这样的关联与年龄无明显变化。最好从CN中辨别aMCI的结构在<85和≥85年龄段人群中不同:在<85人群中为皮层、壳核、海马旁回、楔前叶和额叶皮质,≥85年龄段人群中为海马、三角部、颞极。 naMCI 和 CN之间的差异很小而且在样本中并无意义。WMHs近期没有与MCI亚型显著相关。结论–结构MRI区分aMCI、但不区分naMCI,从老年人中的CN。最好从CN中辨别aMCI的结构在<85和≥85年龄段人群中不同,表明在年长人群中不同的认知障碍的神经病理基础。
关键词: 高龄,阿尔茨海默病,aMCI,脑萎缩, naMCI,结构磁共振成像。
Current Alzheimer Research
Title:Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians
Volume: 13 Issue: 3
Author(s): Zixuan Yang, Wei Wen, Jiyang Jiang, John D. Crawford, Simone Reppermund, Charlene Levitan, Melissa J. Slavin, Nicole A. Kochan and Robyn L. Richmond, Henry Brodaty, Julian N. Trollor, Perminder S. Sachdev
Affiliation:
关键词: 高龄,阿尔茨海默病,aMCI,脑萎缩, naMCI,结构磁共振成像。
摘要: Underpinnings of mild cognitive impairment (MCI) change with increasing age. We hypothesize that MRI signatures of mild cognitive impairment (MCI) would be different at a higher age compared to younger elders. Methods – 244 participants (71-103 years) from the Sydney Memory and Ageing Study and the Sydney Centenarian Study were categorized as amnestic MCI (aMCI), non-amnestic MCI (naMCI) or cognitively normal (CN). Brain “atrophy” and white matter hyper-intensities (WMHs) associated with MCI subtypes and age effects were examined by general linear models, controlling for confounding factors. Reduced logistic regressions were performed to determine structures that best discriminated aMCI from CN in individuals <85 and those ≥85 years. Results – aMCI was associated with smaller volumes of overall cortex, medial temporal structures, anterior corpus callosum, and select frontal and parietal regions compared to CN; such associations did not significantly change with age. Structures that best discriminated aMCI from CN differed however in the <85 and ≥85 age groups: cortex, putamen, parahippocampal, precuneus and superior frontal cortices in <85 years, and the hippocampus, pars triangularis and temporal pole in ≥85 years. Differences between naMCI and CN were small and non-significant in the sample. WMHs were not significantly associated with MCI subtypes. Conclusions – Structural MRI distinguishes aMCI, but not naMCI, from CN in elderly individuals. The structures that best distinguish aMCI from CN differ in those <85 from those ≥85, suggesting different neuropathological underpinnings of cognitive impairment in the very old.
Export Options
About this article
Cite this article as:
Zixuan Yang, Wei Wen, Jiyang Jiang, John D. Crawford, Simone Reppermund, Charlene Levitan, Melissa J. Slavin, Nicole A. Kochan and Robyn L. Richmond, Henry Brodaty, Julian N. Trollor, Perminder S. Sachdev , Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians, Current Alzheimer Research 2016; 13 (3) . https://dx.doi.org/10.2174/1567205013666151218150534
DOI https://dx.doi.org/10.2174/1567205013666151218150534 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Concise Review on Multidimensional Silver Nanoparticle Health Aids and Threats
Current Drug Therapy Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Coenzyme Q10 and Neurological Diseases: An Update
Letters in Drug Design & Discovery Patterns of Gray and White Matter Changes in Individuals at Risk for Alzheimer’s Disease
Current Alzheimer Research Dexmedetomidine Use in General Anaesthesia
Current Drug Targets Radiopharmaceuticals in Neurological and Psychiatric Disorders
Current Clinical Pharmacology Substrates, Inhibitors and Activators of P-glycoprotein: Candidates for Radiolabeling and Imaging Perspectives
Current Topics in Medicinal Chemistry Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles
Current Medicinal Chemistry Needle in a Haystack: Targeting Specific Glucuronidases Amid the Human Microbiome
Current Enzyme Inhibition Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Update on the Slow Delayed Rectifier Potassium Current (IKs): Role in Modulating Cardiac Function
Current Medicinal Chemistry Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical Findings
Current Drug Discovery Technologies Genetic Polymorphism of Organic Anion and Cation Transporters: Pharmacokinetic and Pharmacodynamic Consequences in Pharmacotherapy
Current Pharmacogenomics Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
Current Drug Targets New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5’-Phosphate Decarboxylases
Current Medicinal Chemistry Pharmacological Strategies for Neuroprotection in Traumatic Brain Injury
Mini-Reviews in Medicinal Chemistry Long-Term Outcome of Infants Born Late Preterm
Current Pediatric Reviews Geriatric Psychopharmacology in Acute Settings
Current Psychopharmacology Inhibition of Human Serine Racemase, an Emerging Target for Medicinal Chemistry
Current Drug Targets Comparative Anatomy, Physiology and In Vitro Models of the Blood-Brain and Blood-Retina Barrier
Current Medicinal Chemistry - Central Nervous System Agents